Literature DB >> 17671233

C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.

Christine Yeamans1, Dehua Wang, Ido Paz-Priel, Bruce E Torbett, Daniel G Tenen, Alan D Friedman.   

Abstract

The PU.1 gene contains a 237-base pair distal enhancer located 14 kilobases upstream of its promoter. We have identified 2 sites within the PU.1 enhancer that strongly bind C/EBPalpha in a gel shift assay, and interaction with endogenous C/EBPalpha was confirmed by chromatin immunoprecipitation. Mutation of these DNA elements reduced activity of a distal enhancer-promoter construct 2- or 5-fold in a myeloid cell line, while mutation of a weaker C/EBPalpha-binding site located in the promoter minimally reduced activity in this context. These findings strengthen the link between C/EBPalpha and PU.1 expression. Reduction of C/EBPalpha activity in cases of acute myeloid leukemia may therefore contribute to transformation by reducing PU.1 levels. In addition, induction of PU.1 by C/EBPalpha during normal hematopoiesis may contribute to stem cell commitment to the myeloid lineages and further commitment to monopoiesis. Consistent with a requirement for C/EBPalpha induction of PU.1 during myeloid development, we demonstrate that C/EBPalpha induces monocytic development when expressed in PU.1(+/+), PU.1(+/-), or PU.1(+/kd) marrow myeloid progenitors but induces granulocyte lineage commitment in PU.1(kd/kd) cells lacking the PU.1 distal enhancer and does not induce either lineage in PU.1(-/-) cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671233      PMCID: PMC2200910          DOI: 10.1182/blood-2007-03-080291

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo.

Authors:  B T Porse; X Xu; B Lindberg; U M Wewer; L Friis-Hansen; C Nerlov
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

2.  BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

Authors:  Danilo Perrotti; Vincenzo Cesi; Rossana Trotta; Clara Guerzoni; Giorgia Santilli; Kenneth Campbell; Angela Iervolino; Fabrizio Condorelli; Carlo Gambacorti-Passerini; Michael A Caligiuri; Bruno Calabretta
Journal:  Nat Genet       Date:  2001-12-20       Impact factor: 38.330

3.  Regulation of B lymphocyte and macrophage development by graded expression of PU.1.

Authors:  R P DeKoter; H Singh
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

4.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

Authors:  T Pabst; B U Mueller; P Zhang; H S Radomska; S Narravula; S Schnittger; G Behre; W Hiddemann; D G Tenen
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

Review 5.  Transcriptional regulation of granulocyte and monocyte development.

Authors:  Alan D Friedman
Journal:  Oncogene       Date:  2002-05-13       Impact factor: 9.867

6.  PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.

Authors:  K L Anderson; K A Smith; H Perkin; G Hermanson; C G Anderson; D J Jolly; R A Maki; B E Torbett
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

7.  Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.

Authors:  Yutaka Okuno; Gang Huang; Frank Rosenbauer; Erica K Evans; Hanna S Radomska; Hiromi Iwasaki; Koichi Akashi; Francoise Moreau-Gachelin; Youlin Li; Pu Zhang; Berthold Göttgens; Daniel G Tenen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

8.  Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.

Authors:  Pu Zhang; Junko Iwasaki-Arai; Hiromi Iwasaki; Maris L Fenyus; Tajhal Dayaram; Bronwyn M Owens; Hirokazu Shigematsu; Elena Levantini; Claudia S Huettner; Julie A Lekstrom-Himes; Koichi Akashi; Daniel G Tenen
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

9.  AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

Authors:  T Pabst; B U Mueller; N Harakawa; C Schoch; T Haferlach; G Behre; W Hiddemann; D E Zhang; D G Tenen
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

10.  PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis.

Authors:  Aleksandar Dakic; Donald Metcalf; Ladina Di Rago; Sandra Mifsud; Li Wu; Stephen L Nutt
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

View more
  57 in total

1.  Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.

Authors:  Goutam Ghosh; Indira V Subramanian; Neeta Adhikari; Xiaoxiao Zhang; Hemant P Joshi; David Basi; Y S Chandrashekhar; Jennifer L Hall; Sabita Roy; Yan Zeng; Sundaram Ramakrishnan
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  Meeting report: Seventh International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia, Annapolis, MD, May 13-16, 2007.

Authors:  Linda Wolff; Steven J Ackerman; Giuseppina Nucifora
Journal:  Exp Hematol       Date:  2008-03-04       Impact factor: 3.084

3.  C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.

Authors:  Julia E Dooher; Ido Paz-Priel; Simone Houng; Albert S Baldwin; Alan D Friedman
Journal:  Mol Cancer Res       Date:  2011-08-03       Impact factor: 5.852

Review 4.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

5.  The homeobox transcription factor VentX controls human macrophage terminal differentiation and proinflammatory activation.

Authors:  Xiaoming Wu; Hong Gao; Weixiong Ke; Roger W Giese; Zhenglun Zhu
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

6.  Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBPα.

Authors:  Hong Guo; Theresa Barberi; Rahul Suresh; Alan D Friedman
Journal:  J Immunol       Date:  2018-07-30       Impact factor: 5.422

7.  Early life stress perturbs the maturation of microglia in the developing hippocampus.

Authors:  Jean-Christophe Delpech; Lan Wei; Jin Hao; Xiaoqing Yu; Charlotte Madore; Oleg Butovsky; Arie Kaffman
Journal:  Brain Behav Immun       Date:  2016-06-11       Impact factor: 7.217

Review 8.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

9.  A quantitative model of transcriptional regulation reveals the influence of binding location on expression.

Authors:  Kenzie D MacIsaac; Kinyui A Lo; William Gordon; Shmulik Motola; Tali Mazor; Ernest Fraenkel
Journal:  PLoS Comput Biol       Date:  2010-04-29       Impact factor: 4.475

10.  Stress hematopoiesis is regulated by the Krüppel-like transcription factor ZBP-89.

Authors:  Xiangen Li; Rachael D Romain; Dongsu Park; David T Scadden; Juanita L Merchant; M Amin Arnaout
Journal:  Stem Cells       Date:  2014-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.